Home > Healthcare & Medical Devices > Breast Imaging Market

Breast Imaging Market - By Technology (Ionizing, Non Ionizing), By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers) – Global Forecast to 2032

  • Report ID: GMI3893
  • Published Date: Jun 2023
  • Report Format: PDF

Breast Imaging Industry Analysis

Breast Imaging Market size was valued at over USD 5 billion in 2022 and is projected to reach more than USD 12 billion by 2032. Breast imaging consist of various medical imaging techniques to visualize and examine the breast tissue for the detection and evaluation of breast abnormalities, including both benign and malignant conditions.

Breast Imaging Market

To get more details on this report: Request Free Sample PDF

It involves the use of different modalities such as mammography,  breast ultrasound, magnetic resonance imaging (MRI), positron emission tomography (PET), and others for the diagnosis and screening of breast-related conditions. Advancements in imaging technology, increasing prevalence of breast cancer, rising awareness about early breast cancer detection and the implementation of breast cancer screening programs by governments and healthcare organizations are few aspects driving the market growth.

The growing prevalence rate of breast cancer worldwide is the primary factor impelling the breast imaging market gains. Breast cancer is one of the most commonly diagnosed cancer globally accounting for around 12.5% of annual cancer cases worldwide, thereby making it the most prevalent cancer worldwide. Women are more prone to suffer from breast cancer as compared to men. As per estimates from the World Health Organization (WHO), about 0.5-1% of men suffer from breast cancer.

Moreover, the report from the 2020 National Cancer Registry Program predicts that by 2025, there will have been more than 230,000 cases of breast cancer among women in India. Thus, the continuously expanding number of breast cancer cases will lead to an increasing demand for early detection of breast cancer worldwide.

COVID-19 Impact

The COVID-19 pandemic significantly impacted the world economy and negatively affected the breast imaging market revenue. Initially, the market suffered a setback due to the commencement of the lockdown and stringent regulations imposed by the authorities during the lockdown.

In addition, the worldwide supply chain was disrupted, impacting the production and shipping of breast imaging systems. The pandemic caused a strain on the hospitals and various healthcare facilities globally, resulting in adverse financial constraints that led to reduced expenditures on capital equipment for products and services that breast imaging manufacturers were offering. Additionally, a reluctance among the population base towards breast cancer screening programs owing to the fear of the COVID-19 led to a further decline in the product adoption rate.

However, the increasing adoption of diagnostic screenings for breast cancer through several breast imaging devices countered the negative impact that the COVID-19 pandemic initially had on the market progression.

Breast Imaging Market Trends

Rising awareness related to breast cancer, its diagnosis as well as treatment alternatives owing to numerous awareness campaigns will stimulate the market expansion in the forthcoming years. Moreover, growing knowledge regarding the availability of technologically advanced diagnostic equipment in developed countries as well as developing nations will boost the market development.

For instance, in Australia, the National Breast Cancer Foundation, Inc. recognizes October as breast cancer awareness month, annually. The primary aim of the annual campaign is to improve the overall knowledge regarding early detection and prevention of breast cancer among women. Similarly, the European Commission’s Initiatives for Breast Cancer focuses upon contributing to improve overall health and to reduce health disparities throughout Europe by safeguarding the quality of breast cancer services.

Likewise, increasing evidence-based recommendations for breast cancer services in Europe, voluntary European quality assessment scheme for breast cancer services based on the EU legislative framework on accreditation initiatives and government funding will encourage breast cancer screening at a large scale.

Breast Imaging Technology Segmentation

Global Breast Imaging Market Size, By Technology,

To get more details on this report: Request Free Sample PDF

The breast imaging market by technology is segmented into ionizing and non-ionizing breast imaging. The ionizing segment is further segmented into mammography, cone-beam computed tomography (CBCT), positron emission tomography & computed tomography (PET-CT), positron emission mammography (PEM) and molecular breast imaging (MBI). The non-ionizing segment is categorized into MRI, thermography, ultrasound, optical imaging, automated whole-breast ultrasound and electric impedance tomography. Further, mammography segment is subdivided into analog mammography, full-field digital mammography and digital breast tomosynthesis.

The ionizing breast imaging segment is expected to witness CAGR of 8.4% by 2032. Rising prevalence of breast cancer globally coupled with increasing awareness about the importance of early detection are driving the demand for ionizing breast imaging technologies. Governments and healthcare organizations are implementing breast cancer screening programs and promoting awareness campaigns. Also, growing need for mammography modalities owing to integration of advanced technologies such as 3D mammography and digital breast tomosynthesis for precised cancer detection.

Breast Imaging End User Segmentation

Global Breast Imaging Market Share, By End-use

To get more details on this report: Request Free Sample PDF

The breast imaging market by end user is categorized into hospitals, diagnostic imaging centers, ambulatory surgical centers and others. Hospitals segment held largest revenue size accounting for over USD 2 billion in 2022.The high segment growth is owing increasing prevalence of breast cancer worldwide.

Hospitals are incorporating breast imaging technology into their cancer screening and diagnostic services, utilizing the latest trends to provide more accurate, efficient, and accessible breast cancer screening and diagnostic services to their patients bolstering segmental evolution potential. Increasing usage of advanced imaging technologies in hospital settings for screening breast tissues providing effective outcomes along with presence of skilled professionals will contribute towards its higher revenue share.

Breast Imaging Regional Analysis

U.S. Breast Imaging Market Size,

U.S. breast imaging market accounted for over USD 2 billion in 2022. Rising prevalence rate of breast cancer across the nation is driving the product requirement. For instance, in 2022, according to American Cancer Society, approximately 339,250 new cases of breast cancer and second most cause of mortality related to cancer among women in the U.S. Rising focus towards early detection and screening leading to a higher demand for breast imaging technologies in the U.S.

Furthermore, adoption of sophisticated imaging modalities such as contrast-enhanced mammography and digital breast tomosynthesis (DBT) among clinical facilities for improved accuracy and detection rates of breast abnormalities will accelerate market revenue size. Further, high healthcare spending on cancer diagnostics and management, favorable reimbursement scenario will boost the U.S. market in near future.

Breast Imaging Industry Leaders

Some of the notable key breast imaging market players operating in the breast imaging industry include GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Gamma Medica, Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, SonoCine, Inc., Toshiba Corporation, Dilon Technologies, Inc., Aurora Imaging Technology, Inc., Canon Inc., Allengers, Planmed OY and Delphinus imaging technologies, Inc. among others.

Breast Imaging Industry News:

  • In November 2022, Google Health, a part of Alphabet Inc. collaborated with iCAD for integration of its novel mammography AI tool into iCAD's breast imaging solutions. Such partnerships enhanced operational capabilities as well as strengthened product offerings in the significant market. 
  • In March 2022, Philips received 510(k) clearance from U.S. FDA for its collaboration live integrated tele-ultrasound for remote diagnostic use to additional mobile platforms. This technology is also available on EPIQ and Affiniti for better efficiency and efficacy. This has provided competitive edge in the significant market.

Breast imaging market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Technology (USD Million)

  • Ionizing
    • Mammography
      • Analog Mammography
      • Full-field Digital Mammography
      • Digital Breast Tomosynthesis
    • Cone-Beam Computed Tomography (CBCT)
    • Positron Emission Tomography & Computed Tomography (PET-CT)
    • Positron Emission Mammography (PEM)
    • Molecular Breast Imaging (MBI)
  • Non-Ionizing
    • MRI
    • Thermography
    • Ultrasound
    • Optical Imaging
    • Automated Whole-breast Ultrasound
    • Electric Impedance Tomography

By End User (USD Million)

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Switzerland
    • The Netherlands
    • Poland
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Iran


Authors: Rupali Swain

Frequently Asked Questions (FAQ) :

Breast imaging industry share was over USD 5 billion in 2022 and is estimated to reach more than USD 12 billion by 2032 due to the rising implementation of breast cancer screening programs by governments and healthcare organizations.

The hospitals end-user segment accounted for over USD 2 billion in 2022 owing to the rising need to provide more accurate, efficient, and accessible breast cancer screening and diagnostic services to patients.

Demand for breast imaging in the U.S. exceeded USD 2 billion in 2022 due to the rising prevalence rate of breast cancer in the country.

Key breast imaging industry players include GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Gamma Medica, Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, SonoCine, Inc., Toshiba Corporation, Dilon Technologies, Inc., Aurora Imaging Technology, Inc., and Canon Inc.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 418
  • Countries covered: 30
  • Pages: 210
Inquiry Before Buying

Budget constraints? Get in touch with us for special pricing

Request Discount